Management of Breakthrough Agitation with Haloperidol and Quetiapine

Introduction to Combined Therapy

The National Comprehensive Cancer Network recommends reducing PRN haloperidol dose to 0.5-1 mg every 4-6 hours when adding quetiapine 50 mg twice daily to a scheduled haloperidol regimen, to prevent excessive sedation and cumulative antipsychotic effects 1, 2, 3
Standard PRN haloperidol dosing for breakthrough agitation or delirium ranges from 0.5-2 mg every 4-6 hours, with the lower end of this range (0.5-1 mg) being most appropriate for patients with a substantial scheduled haloperidol burden 1, 2, 3

The National Comprehensive Cancer Network suggests that combining sedating antipsychotics, such as quetiapine, increases the risk of excessive drowsiness, falls, and respiratory depression 4
Starting quetiapine at 50 mg BID is reasonable, but close monitoring for oversedation is necessary 4
PRN quetiapine 25-50 mg every 6-8 hours is an alternative to PRN haloperidol, which avoids further increasing haloperidol exposure and associated EPS risk 2, 3

The American College of Emergency Physicians recommends watching for complications such as excessive sedation or somnolence, orthostatic hypotension, EPS or akathisia, and QTc prolongation when using combined antipsychotics 4, 5
It is recommended to avoid combining haloperidol and quetiapine with benzodiazepines unless absolutely necessary, as this significantly increases sedation and respiratory depression risk 4